1-2 of 2
Fabio Da Roit
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glycoengineered CD20 Antibody Obinutuzumab Activates Neutrophils and Mediates Phagocytosis Through CD16B More Efficiently Than Rituximab

Josée Golay, PhD, Fabio Da Roit, BSc, Luca Bologna, BSc, Claudia Ferrara Koller, PhD, Jeanette H. W. Leusen, PhD, Alessandro Rambaldi, MD, Christian Klein, PhD, Martino Introna, MD
Journal: Blood
Blood (2013) 122 (21): 4419.
https://doi.org/10.1182/blood.V122.21.4419.4419
Published: 2013
Journal Articles

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab

Josée Golay, Fabio Da Roit, Luca Bologna, Claudia Ferrara, Jeanette H. Leusen, Alessandro Rambaldi, Christian Klein, Martino Introna
Journal: Blood
Blood (2013) 122 (20): 3482–3491.
https://doi.org/10.1182/blood-2013-05-504043
Published: 2013
Includes: Supplemental data